Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Anti-idiotypic
Patent
1984-05-11
1986-06-24
Shippen, Michael L.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Anti-idiotypic
A61K 3324
Patent
active
045967105
ABSTRACT:
The present invention relates to the application of gallium chloride as drug particularly useful for the treatment of malignant tumors, and to the pharmaceutical compositions particularly intended for oral administration and containing from 100 to 500 mg of active ingredient per unit dose.
REFERENCES:
Villini, Chem. Abst., 61: 6252(a) (1963).
Collery, Trace Substances in Environmental Health-XV, pp. 208-216 (1981).
Adamson, Cancer Chemother. Rep., Part 1, 59, pp. 599-610 (1975).
Anghileri, Arzneimittel-Forschung, 25, pp. 793-795 (1975).
Hart, Proc. Nat. Acad. Sci., U.S., 68, pp. 1623-1626 (1971).
Collery, Magnesium-Bull., 3, pp. 23-25 (1981).
Les Laboratoires Meram
Shippen Michael L.
LandOfFree
Gallium chloride as a new anti-cancerous drug does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gallium chloride as a new anti-cancerous drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gallium chloride as a new anti-cancerous drug will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2084728